Does Ultherapy actually work?

Ultherapy is the brand name for microfocused ultrasound with visualization (MFU-V), a non-surgical device that uses sound waves to heat deep skin layers and trigger new collagen growth. The honest answer is that it does produce real, measurable tightening for the right person, but the effect is modest, gradual, and far smaller than a surgical lift. This review walks through how it works, what the published studies actually found, where the evidence is weak or industry-funded, and who is a reasonable candidate.

What Ultherapy is and how it works

Ultherapy delivers focused ultrasound energy to precise depths beneath the skin. Unlike the diagnostic ultrasound used in pregnancy scans, this energy is concentrated to a single point, where it raises tissue temperature high enough to create a tiny zone of controlled thermal injury.

Each pulse produces a thermal coagulation point of roughly 1 cubic millimeter. The device is designed to place these points at set depths, usually 1.5 mm, 3.0 mm, and 4.5 mm, depending on the transducer. The deepest depth (4.5 mm) reaches the superficial muscular aponeurotic system, the same connective-tissue layer a surgeon tightens during a facelift. The "visualization" part of MFU-V matters here: a built-in imaging screen lets the operator see the layers before firing, so energy lands in the dermis and fibrous tissue rather than on bone or in fat.

The heat does two things. First, it denatures (unwinds) existing collagen, which causes a small amount of immediate tightening. Second, and more important, the controlled injury kicks off a wound-healing response over the following weeks and months. Systematic reviews report that tissue temperatures in the treatment zone reach roughly 60 to 70 degrees Celsius, enough to denature collagen and trigger neocollagenesis, the formation of new collagen, along with elevated heat shock protein activity around three months after treatment (microfocused ultrasound mechanism review, IJERPH 2023, PMID 36674277).

This is why results are not instant. The new collagen builds over two to six months, which is the window in which most patients and investigators report visible change.

One more point on mechanism helps set expectations. Ultherapy does not remove skin and it does not add volume. It tries to firm and slightly lift the tissue you already have by stimulating your own repair system. If your skin still has decent elasticity, that repair response is stronger and the result is better. If elasticity is mostly gone, there is less for the collagen response to work with, which is one reason the studies that excluded heavily lax skin reported the cleanest results. The treatment works with your biology rather than overriding it, so the same machine on two different people can give very different outcomes.

Where Ultherapy fits among skin treatments

It helps to place Ultherapy on a spectrum. Topical creams sit at the gentle end. Surgery sits at the aggressive end. Energy devices like Ultherapy live in the middle, promising some lift without cutting.

Ultherapy is positioned as the option for someone with mild to moderate skin laxity who wants some improvement but is not ready for surgery. It is not a facelift substitute, and reputable studies do not claim it is.

What the evidence actually shows

This is the part that matters for a "does it work" question. There is a real body of published research, but it has serious limitations you should understand before paying for treatment.

The headline numbers

The largest pooled analysis to date is a 2024–2025 systematic review and meta-analysis in Aesthetic Surgery Journal that screened more than 4,000 references and included 42 studies (MFU-V systematic review and meta-analysis, PMID 39540440). Across the studies it could pool, the findings were:

• Investigators rated roughly 89 percent of patients as improved on a global aesthetic scale.
• Patients themselves reported improvement about 84 percent of the time.
• Overall satisfaction was about 84 percent, but this varied a lot by body area: about 93 percent for face and neck versus about 63 percent for other areas.
• Average pain during treatment was about 4.85 on a 0-to-10 scale, which is moderate.

A separate 2023 systematic review in IJERPH looked specifically at how much physical lift occurs and found smaller, more sobering numbers (facial skin tightening systematic review, PMID 36674277):

• Brow lift measured between 0.47 and 1.7 mm at 90 days. That is under two millimeters, a change you may need before-and-after photos to see.
• Submental (under-chin) area reduction of roughly 26 to 45 square millimeters on profile photographs.
• On patient self-reports, "mild improvement" rose from about 42 percent at 90 days to about 53 percent at 360 days, while the "no change" group shrank from 25 percent to 5 percent.

So the picture is consistent across reviews: most people notice something, but the average improvement is mild, and the millimeter-level lift is real but small.

Why you should read those numbers with caution

Here is where honesty matters. The evidence base has real problems, and the people running and funding many of these studies have a financial interest in good results.

Industry funding. The large meta-analysis disclosed that it was funded by Merz, the company that owns Ultherapy, and several authors reported payments from Merz and other device makers (PMID 39540440). That does not automatically make the findings wrong, but funded research tends to report more favorable outcomes, so the numbers should be treated as a best case rather than a neutral estimate.

Weak study designs. Of the 42 studies in the meta-analysis, only 2 were controlled trials. Most were before-and-after case series with no comparison group, no randomization, and no blinding. The authors flagged confounding bias in essentially all of the non-randomized studies and high statistical heterogeneity. Their own conclusion was that "well-designed, controlled trials are needed" (PMID 39540440).

Cherry-picked patients. Most studies excluded people with severe sagging, with a body mass index over 30, and almost everyone enrolled was a woman (over 90 percent). Results also got worse as baseline laxity increased (PMID 36674277). In plain terms, the studies were stacked toward the patients most likely to respond, so real-world results in a broader population may be weaker. An earlier 2021 review reached the same cautious verdict, calling the evidence promising but limited by study quality (micro-focused ultrasound efficacy review, Cureus 2021, PMID 35003992).

Thin long-term data. Most follow-up stopped at six months, with a maximum around one year. There is little published evidence on how long results last beyond 12 months, and collagen continues to age, so the lift is not permanent.

Bottom line on evidence: Ultherapy produces a small but genuine tightening effect that most well-selected patients perceive as an improvement. The strongest objective data (millimeter brow lift, profile-photo measurements) is modest. The most impressive-sounding data (satisfaction percentages) is the softest and most prone to bias. Treat marketing claims of a "non-surgical facelift" as overstated.

How to grade this kind of evidence

It helps to think about what each type of finding is worth. Not all "92 percent of patients improved" claims are equal, and Ultherapy research is a good example of why.

The most trustworthy evidence comes from randomized, controlled, blinded trials, where some patients get the real treatment and others get a sham, and neither the patient nor the rater knows which is which. Almost none of the Ultherapy literature is built this way. Without a control group, you cannot separate the treatment's effect from natural variation, from the patient simply hoping to look better, or from the photographer's lighting changing between visits.

The next tier down is objective measurement, like a ruler measuring brow height on standardized photos. This is harder to fake than an opinion, which is why the 0.47 to 1.7 mm brow lift figure carries more weight than the satisfaction percentages, even though it sounds less impressive (PMID 36674277).

The weakest tier is subjective rating, where a patient or an investigator looks and decides whether things "improved." These ratings are where the big, marketing-friendly numbers come from, and they are the easiest to bias, especially when the rater knows everyone got the treatment and the study was paid for by the manufacturer.

So when you see Ultherapy advertised with a high success rate, ask which tier that number came from. The honest read of the literature is that the objective, hard-to-fudge numbers are modest, while the soft, easy-to-bias numbers are high. Reality is probably somewhere in between, closer to "a real but subtle improvement" than to the glossy before-and-after photos in a clinic brochure.

FDA status

Ultherapy is FDA-cleared, not FDA-approved, and the distinction matters. Clearance through the 510(k) and De Novo pathways means the device was allowed to market based on safety and on the manufacturer's clinical data, not the higher bar of large randomized "approval" trials.

The device received its first clearance in 2009 for non-invasive brow lift. Later clearances expanded the labeled uses. FDA's own device database confirms a clearance for the Ulthera System on October 2, 2012 (record K121700) for lifting the neck and submental tissue, and a December 2013 clearance (K132028) covering ultrasound visualization, with newer clearances for the updated PRIME systems in 2025 (FDA 510(k) device records for Ulthera, openFDA). A 2014 clearance added improvement of lines and wrinkles on the décolletage.

What this means for you: the labeled, evidence-backed uses are brow lift, lifting of the neck and under-chin area, and décolletage lines. Anything beyond that (arms, abdomen, knees) is off-label, with thinner evidence.

What a treatment session is actually like

Knowing the practical flow helps you judge whether the cost and discomfort are worth a modest result.

A typical session starts with the provider mapping the treatment area and applying ultrasound gel. The operator selects transducers for the right depths, often combining a deeper 4.5 mm pass for lifting with shallower 3.0 mm and sometimes 1.5 mm passes for the dermis. Using the visualization screen, the provider checks that each line of energy lands in tissue rather than over bone, then delivers rows of pulses across the face, jawline, under-chin, or neck.

A full face and neck treatment usually takes 30 to 90 minutes. Most people feel brief heat or a prickling sensation with each pulse, strongest over bonier spots. There is essentially no recovery time. You can drive home and return to normal activity the same day, which is a real advantage over surgery or more aggressive resurfacing.

Number of sessions is a common point of confusion. Marketing often implies "one and done." In practice, many people get a single session and wait to see results over the next few months, but those with more laxity may be offered a second session or periodic maintenance. Because the effect fades as skin continues to age, a touch-up every one to two years is a reasonable expectation rather than a sign the first treatment failed.

On cost, Ultherapy is not cheap, and price varies widely by region and by how much area is treated. Full face and neck sessions commonly run from roughly one thousand to several thousand dollars, with smaller areas costing less. It is not covered by insurance because it is cosmetic. When you weigh that against a modest, gradual result, the value question is real, and it is fair to compare it against the alternatives before committing.

Safety and side effects

On safety, the record is reassuring. Because the energy is focused below the surface and spares the epidermis, the skin is rarely broken and downtime is minimal.

Across systematic reviews, the common side effects were mild and short-lived (PMID 39540440, PMID 36674277):

• Redness (erythema), nearly universal and fading within hours.
• Swelling and mild bruising.
• Tenderness or soreness along treated areas.
• Temporary tingling or numbness, usually resolving over days to a few weeks.

Uncommon effects, reported in roughly 2 percent of patients in one review, included altered sensation (dysesthesia), small welts or striations, and rare superficial burns along the jaw. The 2023 review noted no serious events such as permanent nerve damage, scarring, or pigment change in its pooled data.

That said, rare serious complications are documented in the wider clinical literature and in adverse-event reporting, almost always tied to operator error or treating over a nerve. Temporary weakness of facial muscles can occur if energy is delivered over a motor nerve branch; this is usually transient. Burns and scarring are possible with poor technique. The practical safety lesson is that outcome and risk both depend heavily on the operator. A trained physician or experienced provider using the visualization screen correctly is the single biggest safety variable.

People who should avoid or postpone treatment include those who are pregnant, have active infection or open wounds in the treatment area, have implants or metallic devices near the site, or have severe sagging better addressed surgically.

How it compares to the alternatives

If your goal is tightening, Ultherapy is one tool among several, and it is not automatically the best one for your situation.

Versus radiofrequency (RF) and RF microneedling. RF heats the dermis with electrical energy rather than sound. It tends to be less painful, works at shallower depth, and is often better for skin texture and surface crepiness, while Ultherapy reaches deeper for lifting. Neither is dramatically better in head-to-head data; the choice depends on your skin and goals. Many providers see them as complementary. You can read more in our radiofrequency skin tightening guide.

Versus other focused ultrasound (HIFU) devices. Ultherapy is the device cleared for visualization, meaning the operator can see the tissue layers. Cheaper "HIFU facials" use related ultrasound technology but often lack imaging, so energy placement is less precise. A 2025 systematic review of high-intensity focused ultrasound found generally positive but lower-quality evidence for skin tightening and body contouring (high-intensity focused ultrasound systematic review).

Versus Morpheus8 and RF microneedling. These create micro-injuries with tiny needles plus RF energy, which adds a skin-resurfacing benefit Ultherapy does not have, at the cost of more downtime. Our Morpheus8 evidence review covers that data.

Versus a surgical facelift. Surgery removes and repositions tissue and delivers a result no energy device can match for significant sagging. Ultherapy cannot replace it. For mild laxity in someone not ready for surgery, Ultherapy is a reasonable middle step.

For a broader view of energy and injectable options ranked by evidence, see our comparison of top anti-aging treatments and our overview of clinical studies behind popular beauty treatments.

Who Ultherapy is right for, and who should skip it

Ultherapy makes the most sense for a specific person. The published evidence essentially describes the ideal candidate.

Good candidates tend to be:

• Adults in their 30s to early 60s with mild to moderate skin laxity.
• People bothered by early sagging of the brow, jawline, under-chin, or neck.
• Those with reasonably good skin elasticity remaining, since the treatment relies on the body's own collagen response.
• People who want gradual, natural-looking change and accept a modest result.
• Those who cannot or do not want surgery and have realistic expectations.

Poor candidates include:

• People with severe, heavy sagging or significant excess skin, who will be disappointed and are better served by surgery.
• Those expecting a dramatic, facelift-level change from one session.
• People with a high body mass index, where studies showed weaker results.
• Anyone who is pregnant, has an active skin infection, or has implants or metal near the treatment area.

Expectations are the deciding factor. Someone who understands they are buying a subtle, slow, modest improvement is usually satisfied. Someone who expects to look ten years younger overnight is usually not.

Frequently Asked Questions

How long does Ultherapy take to work?

Results are gradual because they depend on new collagen forming. A small amount of tightening may be visible early from collagen contraction, but the meaningful change builds over two to six months. Studies measured continued improvement out to about a year (PMID 36674277).

How long do the results last?

Most studies followed patients to six months, with some data at one year, where mild improvement persisted. There is little published data beyond 12 months. Because skin keeps aging, results are not permanent, and many providers suggest a maintenance session every one to two years.

Is Ultherapy painful?

It can be moderately uncomfortable. Across pooled data, average pain was around 4 to 5 on a 0-to-10 scale, often described as brief heat or prickling along the energy lines, especially over bony areas. Providers use settings and sometimes pain medication to manage it.

Is Ultherapy better than a facelift?

No. A surgical facelift produces a far larger and longer-lasting result for significant sagging. Ultherapy is a non-surgical option for mild to moderate laxity with no downtime. They solve different problems and should not be marketed as equivalent.

Is Ultherapy safe?

For most people it is safe, with side effects that are usually mild and temporary, such as redness, swelling, and brief numbness. Serious problems like burns or temporary muscle weakness are rare and almost always linked to operator error, which is why provider training matters more than almost anything else.

This article is for general information and is not medical advice. Talk to a licensed physician or qualified medical provider before starting any aesthetic treatment.